Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in twin gestations: a systematic review and meta-analysis

Nenhuma Miniatura disponível
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
MOSBY-ELSEVIER
Autores
CONDE-AGUDELO, Agustin
ROMERO, Roberto
REHAL, Anoop
SERRA, Vicente
FONSECA, Eduardo Da
CETINGOZ, Elcin
SYNGELAKI, Argyro
PERALES, Alfredo
HASSAN, Sonia S.
Citação
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, v.229, n.6, p.599-+, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE: To evaluate the efficacy of vaginal progesterone for the prevention of preterm birth and adverse perinatal outcomes in twin gestations.DATA SOURCES: MEDLINE, Embase, LILACS, and CINAHL (from their inception to January 31, 2023), Cochrane databases, Google Scholar, bibliographies, and conference proceedings.STUDY ELIGIBILITY CRITERIA: Randomized controlled trials that compared vaginal progesterone to placebo or no treatment in asymptomatic women with a twin gestation.METHODS: The systematic review was conducted according to the Cochrane Handbook for Systematic Reviews of Interventions. The primary outcome was preterm birth <34 weeks of gestation. Secondary outcomes included adverse perinatal outcomes. Pooled relative risks with 95% confidence intervals were calculated. We assessed the risk of bias in each included study, heterogeneity, publication bias, and quality of evidence, and performed subgroup and sensitivity analyses.RESULTS: Eleven studies (3401 women and 6802 fetuses/infants) fulfilled the inclusion criteria. Among all twin gestations, there were no significant differences between the vaginal progesterone and placebo or no treatment groups in the risk of preterm birth <34 weeks (relative risk, 0.99; 95% confidence interval, 0.84-1.17; high-quality evidence), <37 weeks (relative risk, 0.99; 95% confidence interval, 0.92-1.06; high-quality evidence), and <28 weeks (relative risk, 1.00; 95% confidence interval, 0.64-1.55; moderate-quality evidence), and spontaneous preterm birth <34 weeks of gestation (relative risk, 0.97; 95% confidence interval, 0.80-1.18; high-quality evidence). Vaginal progesterone had no significant effect on any of the perinatal outcomes evaluated. Subgroup analyses showed that there was no evidence of a different effect of vaginal progesterone on preterm birth <34 weeks of gestation related to chorionicity, type of conception, history of spontaneous preterm birth, daily dose of vaginal progesterone, and gestational age at initiation of treatment. The frequencies of preterm birth <37, <34, <32, <30, and <28 weeks of gestation and adverse perinatal outcomes did not significantly differ between the vaginal progesterone and placebo or no treatment groups in unselected twin gestations (8 studies; 3274 women and 6548 fetuses/infants). Among twin gestations with a transvaginal sonographic cervical length <30 mm (6 studies; 306 women and 612 fetuses/infants), vaginal progesterone was associated with a significant decrease in the risk of preterm birth occurring at <28 to <32 gestational weeks (relative risks, 0.48-0.65; moderate-to high-quality evidence), neonatal death (relative risk, 0.32; 95% confidence interval, 0.11-0.92; moderate-quality evidence), and birthweight <1500 g (relative risk, 0.60; 95% confidence interval, 0.39-0.88; high-quality evidence). Vaginal progesterone significantly reduced the risk of preterm birth occurring at <28 to <34 gestational weeks (relative risks, 0.41-0.68), composite neonatal morbidity and mortality (relative risk, 0.59; 95% confidence interval, 0.33-0.98), and birthweight <1500 g (relative risk, 0.55; 95% confidence interval, 0.33-0.94) in twin gestations with a transvaginal sonographic cervical length <= 25 mm (6 studies; 95 women and 190 fetuses/infants). The quality of evidence was moderate for all these outcomes. CONCLUSION: Vaginal progesterone does not prevent preterm birth, nor does it improve perinatal outcomes in unselected twin gestations, but it appears to reduce the risk of preterm birth occurring at early gestational ages and of neonatal morbidity and mortality in twin gestations with a sonographic short cervix. However, more evidence is needed before recommending this intervention to this subset of patients.
Palavras-chave
cervical length, multiple gestation, neonatal morbidity, neonatal mortality, prematurity, preterm delivery, progestins, gestogens, transvaginal ultrasound
URI
https://observatorio.fm.usp.br/handle/OPI/57986
Referências
  1. Aboulghar MM, 2012, REPROD BIOMED ONLINE, V25, P133, DOI 10.1016/j.rbmo.2012.03.013
  2. Aboulghar MM, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03033-4
  3. Amorim M, 2018, QUAL LIFE RES, V27, P1119, DOI 10.1007/s11136-017-1771-6
  4. Ananth CV, 2012, SEMIN PERINATOL, V36, P156, DOI 10.1053/j.semperi.2012.02.001
  5. Behrman Richard E., 2007, PRETERM BIRTH CAUSES
  6. Borenstein M, 2013, PREV SCI, V14, P134, DOI 10.1007/s11121-013-0377-7
  7. Briana DD, 2019, J MATERN-FETAL NEO M, V32, P2256, DOI 10.1080/14767058.2018.1425834
  8. Bricker L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008867.pub3
  9. Brizot ML, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.021
  10. Catov JM, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.12.022
  11. Cetingoz E, 2011, ARCH GYNECOL OBSTET, V283, P423, DOI 10.1007/s00404-009-1351-2
  12. Chambers GM, 2014, JAMA PEDIATR, V168, P1045, DOI 10.1001/jamapediatrics.2014.1357
  13. Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0
  14. Comm SP, 2017, AM J OBSTET GYNECOL, V216, pB8, DOI 10.1016/j.ajog.2017.01.006
  15. Conde-Agudelo A, 2020, AM J OBSTET GYNECOL, V223, P42, DOI 10.1016/j.ajog.2019.12.266
  16. Conde-Agudelo A, 2019, OBSTET GYNECOL, V134, P421, DOI 10.1097/AOG.0000000000003391
  17. Crowther CA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002390
  18. Crump C, 2020, EARLY HUM DEV, V150, DOI 10.1016/j.earlhumdev.2020.105187
  19. Crump C, 2020, J PERINATOL, V40, P833, DOI 10.1038/s41372-019-0563-y
  20. D'Antonio F, 2021, EUR J OBSTET GYN R B, V261, P166, DOI 10.1016/j.ejogrb.2021.04.023
  21. Deeks JJ, 2021, Cochrane Handbook for Systematic Reviews of Interventions version 6.2, V2021
  22. Dodd JM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012024.pub2
  23. Dodd JM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005300.pub4
  24. Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529
  25. Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
  26. Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
  27. El-refaie W, 2021, ARCH GYNECOL OBSTET, V304, P1113, DOI 10.1007/s00404-021-06152-1
  28. Elsheikhah AZ, 2010, Ultrasound Obstet Gynecol, V36, P108
  29. de Gamarra-Oca LF, 2021, J PEDIATR-US, V237, P168, DOI 10.1016/j.jpeds.2021.06.004
  30. Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815
  31. Grantz KL, 2019, AM J OBSTET GYNECOL, V221, pB2, DOI 10.1016/j.ajog.2019.04.013
  32. Groussolles M, 2022, AM J OBSTET GYNECOL, V227, DOI 10.1016/j.ajog.2022.01.038
  33. Guyatt G, 2013, J CLIN EPIDEMIOL, V66, P151, DOI 10.1016/j.jclinepi.2012.01.006
  34. Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380
  35. Hayes EJ, 2021, OBSTET GYNECOL, V137, pE145, DOI 10.1097/AOG.0000000000004397
  36. Henderson J, 2004, ARCH DIS CHILD-FETAL, V89, pF542, DOI 10.1136/adc.2003.043851
  37. Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
  38. Higgins JPT., 2019, Cochrane Handbook for Systematic Reviews of Interventions Version 6.2
  39. Howell EM, 2020, MATERN CHILD HLTH J, V24, P546, DOI 10.1007/s10995-019-02869-3
  40. IntHout J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010247
  41. Kalikkot Thekkeveedu Renjithkumar, 2021, Matern Health Neonatol Perinatol, V7, P15, DOI 10.1186/s40748-021-00135-5
  42. Kaur J, 2021, AM J OBSTET GYNECOL, V224, P131, DOI 10.1016/j.ajog.2020.09.019
  43. Khalil A, 2022, BEST PRACT RES CL OB, V84, P179, DOI 10.1016/j.bpobgyn.2022.08.008
  44. Kinzler WL, 2000, J SOC GYNECOL INVEST, V7, P321, DOI 10.1016/S1071-5576(00)00084-8
  45. Klebanoff MA, 2007, AM J OBSTET GYNECOL, V197, p10A, DOI 10.1016/j.ajog.2007.02.030
  46. Li CB, 2019, AM J OBSTET GYNECOL, V220, P543, DOI 10.1016/j.ajog.2018.11.1105
  47. Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006
  48. Lopes KD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012031.pub2
  49. Luke B, 2005, AM J OBSTET GYNECOL, V192, P909, DOI 10.1016/j.ajog.2004.05.057
  50. Manuck TA, 2016, AM J OBSTET GYNECOL, V214, pS9, DOI 10.1016/j.ajog.2016.01.004
  51. Murray SR, 2018, OBSTET GYNAECOL, V20, P57, DOI 10.1111/tog.12460
  52. National Institute for Health and Care Excellence, 2019, NICE guideline NG137 Evidence review
  53. Norman JE, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003506
  54. Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8
  55. Osterman Michelle J K, 2023, Natl Vital Stat Rep, V72, P1
  56. Pacagnella RC, 2022, OBSTET GYNECOL, V139, P41, DOI 10.1097/AOG.0000000000004634
  57. Page M, Cochrane Handbook for Systematic Reviews of Interventions
  58. Palmer TM, 2008, STATA J, V8, P242, DOI 10.1177/1536867X0800800206
  59. Partlett C, 2017, STAT MED, V36, P301, DOI 10.1002/sim.7140
  60. Perales-Marín A, 2021, AM J OBSTET GYNECOL, V225, P111, DOI 10.1016/j.ajog.2021.04.221
  61. Perin J, 2022, LANCET CHILD ADOLESC, V6, P106, DOI 10.1016/S2352-4642(21)00311-4
  62. Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010
  63. Petrou S, 2019, ARCH DIS CHILD, V104, P456, DOI 10.1136/archdischild-2018-315778
  64. Rafael TJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009166.pub2
  65. Rehal A, 2021, AM J OBSTET GYNECOL, V224, DOI 10.1016/j.ajog.2020.06.050
  66. Robbins CL, 2014, AM J OBSTET GYNECOL, V210, P285, DOI 10.1016/j.ajog.2013.09.020
  67. Rode L, 2011, ULTRASOUND OBST GYN, V38, P272, DOI 10.1002/uog.9093
  68. Roman A, 2022, AM J OBST GYNEC MFM, V4, DOI 10.1016/j.ajogmf.2021.100551
  69. Roman A, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.06.047
  70. Roman A, 2020, AM J OBSTET GYNECOL, V222, P637, DOI 10.1016/j.ajog.2020.01.048
  71. Romero R, 2022, ULTRASOUND OBST GYN, V59, P263, DOI 10.1002/uog.24839
  72. Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1
  73. Sanchez-Ramos L, 2022, AM J OBSTET GYNECOL, V227, P338, DOI 10.1016/j.ajog.2022.04.025
  74. Sanchez-Ramos L, 2020, AM J OBSTET GYNECOL, V222, P638, DOI 10.1016/j.ajog.2020.01.049
  75. Sanchez-Ramos L, 2020, AM J OBSTET GYNECOL, V222, P194, DOI 10.1016/j.ajog.2019.09.038
  76. Scher AI, 2002, PEDIATR RES, V52, P671, DOI [10.1203/00006450-200211000-00011, 10.1203/01.PDR.0000032159.88318.5B]
  77. Schmitz T, 2022, AM J OBSTET GYNECOL, V226, P440, DOI 10.1016/j.ajog.2021.10.034
  78. Schunemann HJ., Cochrane Handbook for Systematic Reviews of Interventions version 6.0
  79. Serra V, 2013, BJOG-INT J OBSTET GY, V120, P50, DOI 10.1111/j.1471-0528.2012.03448.x
  80. Shabaan OM, 2018, FACTS VIEWS VIS OBGY, V10, P93
  81. Shi LY, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015987
  82. Stern E, 2018, J MATERN-FETAL NEO M, V31, P3102, DOI 10.1080/14767058.2017.1364725
  83. Stewart LA, 2021, LANCET, V397, P1183, DOI 10.1016/S0140-6736(21)00217-8
  84. Sun X, 2014, JAMA-J AM MED ASSOC, V311, P405, DOI 10.1001/jama.2013.285063
  85. Tingleff T, 2023, BJOG-INT J OBSTET GY, V130, P387, DOI 10.1111/1471-0528.17344
  86. Topp M, 2004, ACTA OBSTET GYN SCAN, V83, P548, DOI 10.1111/j.0001-6349.2004.00545.x
  87. Urquhart C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006172.pub4
  88. Vasak B, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.10.005
  89. Vogel JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070549
  90. Waitzman NJ, 2021, SEMIN PERINATOL, V45, DOI 10.1016/j.semperi.2021.151390
  91. Ward C, 2022, J MATERN-FETAL NEO M, V35, P7962, DOI 10.1080/14767058.2021.1939303
  92. Wood S, 2012, J PERINAT MED, V40, P593, DOI 10.1515/jpm-2012-0057
  93. Yamasmit W, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004733.pub4
  94. Yelland LN, 2018, BJOG-INT J OBSTET GY, V125, P1406, DOI 10.1111/1471-0528.15292

Coleções
Artigos e Materiais de Revistas Científicas - FM/MOG
Artigos e Materiais de Revistas Científicas - LIM/57
Artigos e Materiais de Revistas Científicas - ODS/03